The program is based on 'Welby MyKarte ONC,' (hereafter, MyKarte ONC), a free personal health record (PHR) service by
MyKarte ONC is a PHR service to support cancer patients and healthcare professionals. Patients can easily enter and access data on their daily symptoms and treatment status to centrally manage such information. Also, the program provides optimized information according to cancer types and symptoms based on the patient's record. The PHR service aims at achieving better treatment outcome through these functions which will help patients deepen understanding of the treatment and assist healthcare professionals to see changes in patients' conditions (including adverse reactions and worsening of symptoms) sooner.
With the use of MyKarte ONC, Chugai started to offer the patient support program as described below, starting from
Self-check functions: Patients on treatment with Tecentriq can self-monitor if they have symptoms related to irAE which requires attention by using self-check functions offered by MyKarte ONC. If severe symptoms (according to PRO-CTCAE) are recorded, a message will be displayed to urge the patient to contact a medical institution for telephone counseling, etc. In addition, the patient can report his/her conditions to the physician with the severity based on PRO-CTCAE. By performing the self-check on a regular basis, patients can raise their awareness of important adverse reactions and deepen their understanding of the disease.
Patient-Reported Outcome Common Terminology Criteria for Adverse Events
Information service functions: For the patients who have selected 'Tecentriq/breast cancer' as a drug they currently use when upon registration for MyKarte ONC, the information page on Tecentriq provided by Chugai will be displayed. The seamless access to the information page via MyKarte ONC will increase convenience in gaining information. Comments are also displayed according to the state of entries, which enables patients to further understand their treatments.
'Under CHUGAI DIGITAL VISION 2030, we aim to transform our business by using digital technologies to make Chugai a top innovator in the provision of society-changing healthcare solutions. To achieve this goal, the Value Delivery functions of Chugai consisted of Drug Safety Division, Marketing & Sales Division, and Medical Affairs Division will collaborate to broaden the use of the PHR service,' said Satoko Shisai, Chugai's Vice President, Head of Digital & IT Supervisory Division. 'COVID-19 has brought rapid changes in our lifestyle. Similarly, the communication between patients and healthcare professionals will shift to contactless communication, including online clinical practice. Through this PHR service, patients can routinely record their daily status and share necessary information with healthcare professionals even under the situation where face-to-face communication is limited. In addition, it will contribute to realization of patient-centric healthcare by supporting patients to understand their treatments and proactively engage in their own treatment. Chugai will approach various needs in clinical settings by means of digital technologies, and continue to make efforts to realize patient-centric healthcare.'
Takeru Hiki, Representative Director of
About
Corporate
Representative: Takeru Hiki, CEO
Head Office: 3F Nomura Fudosan Nihonbashi-Honcho Bldg., 2-7-1, Nihonbashi-Honcho, Chuo-ku,
Date of Foundation:
Business Description: Planning, development, and application of digital services for treatment support for patients (PHR)
URL: https://welby.jp/ (Japanese only)
About Chugai
About CHUGAI DIGITAL VISION 2030
URL: https://www.chugai-pharm.co.jp/english/profile/digital/index.html
In CHUGAI DIGITAL VISION 2030, Chugai has set its goal for 2030 to transform its business by using digital technologies to make Chugai a top innovator in the provision of society-changing healthcare solutions. Based on the three basic strategies consisting of 1) Strengthen digital platform, 2) Optimize all value chains, and 3) Digital transformation for drug discovery and development, the company aims to transform its business and provide society-changing healthcare solutions.
Contact:
Tel: +81-3-3273-0881
Email: pr@chugai-pharm.co.jp
(C) 2020 Electronic News Publishing, source